Heme oxygenase 1 is expressed in murine erythroid cells where it controls the level of regulatory heme

Blood

Volumn 123, Issue 14, 2014, Pages 2269-2277

  Garcia Santos, Daniel ^a   Schranzhofer, Matthias ^a   Horvathova, Monika ^b   Jaberi, Mehrad Mojtahed ^a   Bogo Chies, Jose Artur ^c   Sheftel, Alex D ^d   Ponka, Prem ^a  

^a MCGILL UNIVERSITY   (Canada)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d High Impact Editing   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEME; HEME OXYGENASE 1; HEMOGLOBIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL SELECTION; ENZYME DEGRADATION; ERYTHROCYTE CULTURE; ERYTHROID CELL; GENE OVEREXPRESSION; HEMOGLOBIN DETERMINATION; HEMOGLOBIN SYNTHESIS; IRON TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STABLE TRANSFECTION; ANIMAL; ANIMAL EMBRYO; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; ERYTHROPOIESIS; GENE EXPRESSION; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYO, MAMMALIAN; ERYTHROID CELLS; ERYTHROPOIESIS; GENE EXPRESSION; HEME; HEME OXYGENASE-1; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84899127921     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-04-496760     Document Type: Article

References (50)

1. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood. 1997;89(1):1-25. (Pubitemid 26428173)
2. Balla J, Jacob HS, Balla G, Nath K, Eaton JW, Vercellotti GM. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA. 1993;90(20):9285- 9289. (Pubitemid 23315768)
3. Sassa S. Why heme needs to be degraded to iron, biliverdin IXalpha, and carbon monoxide? Antioxid Redox Signal. 2004;6(5):819-824. (Pubitemid 39237934)
4. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997;37:517-554. (Pubitemid 27238886)
5. Maines MD. The heme oxygenase system: update 2005. Antioxid Redox Signal. 2005;7(11-12):1761-1766. (Pubitemid 41768008)
6. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev. 2008;60(1):79-127. (Pubitemid 351439218)
7. Shibahara S, Müller RM, Taguchi H. Transcriptional control of rat heme oxygenase by heat shock. J Biol Chem. 1987;262(27):12889-12892.
8. Keyse SM, Tyrrell RM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci USA. 1989;86(1):99-103. (Pubitemid 19036341)
9. Nascimento AL, Luscher P, Tyrrell RM. Ultraviolet A (320-380 nm) radiation causes an alteration in the binding of a specific protein/protein complex to a short region of the promoter of the human heme oxygenase 1 gene. Nucleic Acids Res. 1993;21(5):1103-1109. (Pubitemid 23155603)
10. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235(4792):1043- 1046. (Pubitemid 17049750)
11. Lee LG, Chen CH, Chiu LA. Thiazole orange: a new dye for reticulocyte analysis. Cytometry. 1986;7(6):508-517.
12. Friend C, Scher W, Holland JG, Sato T. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci USA. 1971;68(2):378-382.
13. Schranzhofer M, Schifrer M, Cabrera JA, et al. Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis. Blood. 2006;107(10):4159-4167. (Pubitemid 43726827)
14. Soe-Lin S, Sheftel AD, Wasyluk B, Ponka P. Nramp1 equips macrophages for efficient iron recycling. Exp Hematol. 2008;36(8):929-937.
15. Dolznig H, Kolbus A, Leberbauer C, et al. Expansion and differentiation of immature mouse and human hematopoietic progenitors. Methods Mol Med. 2005;105:323-344.
16. Kowenz E, Leutz A, Döderlein G, Graf T, Beug H. ts-oncogene- transformed erythroleukemic cells: a novel test system for purifying and characterizing avian erythroid growth factors. Haematol Blood Transfus. 1987;31:199-209.
17. Kina T, Ikuta K, Takayama E, et al. The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br J Haematol. 2000;109(2):280-287. (Pubitemid 30350706)
18. Ponka P, Wilczynska A, Schulman HM. Iron utilization in rabbit reticulocytes. A study using succinylacetone as an inhibitor or heme synthesis. Biochim Biophys Acta. 1982;720(1):96-105. (Pubitemid 12110095)
19. Alam J, Cook JL. How many transcription factors does it take to turn on the heme oxygenase-1 gene? Am J Respir Cell Mol Biol. 2007;36(2):166-174. (Pubitemid 46233469)
20. Maines MD, Trakshel GM. Differential regulation of heme oxygenase isozymes by Sn- and Zn-protoporphyrins: possible relevance to suppression of hyperbilirubinemia. Biochim Biophys Acta. 1992;1131(2):166-174.
21. Chen JJ. Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias. Blood. 2007;109(7):2693-2699.
22. Ponka P, Schulman HM. Acquisition of iron from transferrin regulates reticulocyte heme synthesis. J Biol Chem. 1985;260(27):14717-14721. (Pubitemid 16211005)
23. Laskey JD, Ponka P, Schulman HM. Control of heme synthesis during Friend cell differentiation: role of iron and transferrin. J Cell Physiol. 1986;129(2):185-192. (Pubitemid 17179561)
24. Garrick LM, Gniecko K, Hoke JE, al-Nakeeb A, Ponka P, Garrick MD. Ferric-salicylaldehyde isonicotinoyl hydrazone, a synthetic iron chelate, alleviates defective iron utilization by reticulocytes of the Belgrade rat. J Cell Physiol. 1991;146(3):460-465. (Pubitemid 21910072)
25. Ponka P, Lok CN. The transferrin receptor: role in health and disease. Int J Biochem Cell Biol. 1999;31(10):1111-1137. (Pubitemid 29454549)
26. Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol. 2010;50:323-354.
27. Fujita H, Sassa S. The rapid and decremental change in haem oxygenase mRNA during erythroid differentiation of murine erythroleukaemia cells. Br J Haematol. 1989;73(4):557-560. (Pubitemid 20014900)
28. Alves LR, Costa ES, Sorgine MH, et al. Hemeoxygenases during erythropoiesis in K562 and human bone marrow cells. PLoS ONE. 2011;6(7):e21358.
29. Ponka P. In: Templeton DM, ed. Molecular and Cellular Iron Transport. Boca Raton, FL: CRC Press; 2002:643-678.
30. Cao YA, Kusy S, Luong R, Wong RJ, Stevenson DK, Contag CH. Heme oxygenase-1 deletion affects stress erythropoiesis. PLoS ONE. 2011;6(5):e20634.
31. Tenhunen R. The enzymatic degradation of heme. Semin Hematol. 1972;9(1):19-29.
32. Han AP, Yu C, Lu L, et al. Heme-regulated eIF2alpha kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency. EMBO J. 2001;20(23):6909-6918. (Pubitemid 33134220)
33. Tahara T, Sun J, Igarashi K, Taketani S. Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells. Biochem Biophys Res Commun. 2004;324(1):77-85. (Pubitemid 39311462)
34. Tahara T, Sun J, Nakanishi K, et al. Heme positively regulates the expression of beta-globin at the locus control region via the transcriptional factor Bach1 in erythroid cells. J Biol Chem. 2004;279(7):5480-5487. (Pubitemid 38220572)
35. Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA. 1997;94(20):10919-10924. (Pubitemid 27430836)
36. Kartikasari AE, Wagener FA, Yachie A, Wiegerinck ET, Kemna EH, Swinkels DW. Hepcidin suppression and defective iron recycling account for dysregulation of iron homeostasis in heme oxygenase-1 deficiency [published correction appears in J Cell Mol Med. 2010;14(6B):1874]. J Cell Mol Med. 2009;13(9B):3091-3102.
37. Yachie A, Niida Y, Wada T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999;103(1):129-135. (Pubitemid 29031171)
38. Soe-Lin S, Apte SS, Andriopoulos B Jr, et al. Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo. Proc Natl Acad Sci USA. 2009;106(14):5960-5965.
39. Koury MJ, Ponka P. New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annu Rev Nutr. 2004;24:105-131. (Pubitemid 38938788)
40. Deuel JW, Lutz HU, Misselwitz B, Goede JS. Asymptomatic elevation of the hyperchromic red blood cell subpopulation is associated with decreased red cell deformability. Ann Hematol. 2012;91(9):1427-1434.
41. Yataganas X, Gahrton G, Thorell B. DNA, RNA and hemoglobin during erythroblast maturation. A cytophotometric study. Exp Cell Res. 1970;62(1):254-261.
42. Neuwirt J, Ponka P, Borová J. Evidence for the presence of free and protein-bound nonhemoglobin heme in rabbit reticulocytes. Biochim Biophys Acta. 1972;264(2):235-244.
43. Garrick MD, Scott D, Kulju D, Romano MA, Dolan KG, Garrick LM. Evidence for and consequences of chronic heme deficiency in Belgrade rat reticulocytes. Biochim Biophys Acta. 1999;1449(2):125-136. (Pubitemid 29127280)
44. Shinar E, Rachmilewitz EA. Differences in the pathophysiology of hemolysis of alpha- and beta-thalassemic red blood cells. Ann N Y Acad Sci. 1990;612:118-126.
45. Schrier SL. Pathophysiology of thalassemia. Curr Opin Hematol. 2002;9(2):123-126. (Pubitemid 34171488)
46. Rivella S, Rachmilewitz E. Future alternative therapies for b-thalassemia. Expert Rev Hematol. 2009;2(6):685.
47. Rivella S. Ineffective erythropoiesis and thalassemias. Curr Opin Hematol. 2009;16(3):187-194.
48. Muta K, Krantz SB. Inhibition of heme synthesis induces apoptosis in human erythroid progenitor cells. J Cell Physiol. 1995;163(1):38-50.
49. Browne PV, Shalev O, Kuypers FA, et al. Removal of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemia. J Clin Invest. 1997;100(6):1459-1464. (Pubitemid 27425770)
50. Szuber N, Buss JL, Soe-Lin S, Felfly H, Trudel M, Ponka P. Alternative treatment paradigm for thalassemia using iron chelators. Exp Hematol. 2008;36(7):773-785.